Abstract
To evaluate the effects of parenteral cefoxitin therapy on human fecal flora, we cultured fecal specimens obtained from six patients before, during, and after therapy and used standard methods to identify and quantify all microorganisms. The major changes (observed in at least three patients) included the acquisition or proliferation of group D Streptococcus species, coagulase-negative Staphylococcus species, cefoxitin-resistant members of the family Enterobacteriaceae, Pseudomonas species, and various species of the Bacteroides fragilis group. The most striking finding was ingrowth of Clostridium difficile, noted in five of the six patients. There was concomitant eradication or decrease of cefoxitin-susceptible Enterobacteriaceae family members, Bacteroides species other than the B. fragilis group, Clostridium species other than C. difficile, and Lactobacillus species. These marked alterations of fecal flora may have important clinical consequences.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Finegold S. M. Interaction of antimicrobial therapy and intestinal flora. Am J Clin Nutr. 1970 Nov;23(11):1466–1471. doi: 10.1093/ajcn/23.11.1466. [DOI] [PubMed] [Google Scholar]
- Mulligan M. E., Citron D. M., McNamara B. T., Finegold S. M. Impact of cefoperazone therapy on fecal flora. Antimicrob Agents Chemother. 1982 Aug;22(2):226–230. doi: 10.1128/aac.22.2.226. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rolfe R. D., Helebian S., Finegold S. M. Bacterial interference between Clostridium difficile and normal fecal flora. J Infect Dis. 1981 Mar;143(3):470–475. doi: 10.1093/infdis/143.3.470. [DOI] [PubMed] [Google Scholar]
- Saah A. J., Drusano G. L., Warren J. W., Tenney J. H., Caplan E. S. Cefoxitin-resistant facultative or aerobic gram-negative bacilli in infections associated with the gastrointestinal tract. Ann Intern Med. 1981 Apr;94(4 Pt 1):487–488. doi: 10.7326/0003-4819-94-4-487. [DOI] [PubMed] [Google Scholar]
- Stapley E. O., Birnbaum J., Miller A. K., Wallick H., Hendlin D., Woodruff H. B. Cefoxitin and cephamycins: microbiological studies. Rev Infect Dis. 1979 Jan-Feb;1(1):73–89. doi: 10.1093/clinids/1.1.73. [DOI] [PubMed] [Google Scholar]
- Sutter V. L., Finegold S. M. The effect of antimicrobial agents on human faecal flora: studies with cephalexin, cyclacillin and clindamycin. Soc Appl Bacteriol Symp Ser. 1974;3(0):229–240. [PubMed] [Google Scholar]
- Viscidi R., Willey S., Bartlett J. G. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations. Gastroenterology. 1981 Jul;81(1):5–9. [PubMed] [Google Scholar]
- Wheeler L. A., De Meo M., Kirby B. D., Jerauld R. S., Finegold S. M. High-performance liquid chromatographic assay for measurement of cefoxitin in serum. J Chromatogr. 1980 Sep 12;183(3):357–362. doi: 10.1016/s0378-4347(00)81717-x. [DOI] [PubMed] [Google Scholar]